Intrinsiqs

Is CAMP4 Therapeutics Corporation overvalued?

CAMP4 Therapeutics Corporation (CAMP) — key valuation metrics and fundamentals.

No verdict
Price
$3.85
Fair value
—
Current P/E
—
Normal P/E
27.8
Market cap
$81.8M
Dividend yield
0.0%
Return on equity
-314.1%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CAMP's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.